Table 1

Clinicopathological features and methylation indices of MMs and lung adenocarcinomas

Although 66 MM samples were examined, clinical records were available from only 53 of the cases.
Tumorsn (%)Methylation index (mean ± SD)
Lung adenocarcinoma40 (100)0.32 ± 0.25
Mesothelioma66 (100)0.086 ± 0.11
 Epithelial41 (77)0.10 ± 0.12
 Sarcomatous/mixed12 (23)0.012 ± 0.040
 SV40(+)a32 (48)0.12 ± 0.13
 SV40(−)b34 (52)0.050 ± 0.085
 Survival ≤36 mo49 (92)0.090 ± 0.11
 Survival >36 mo4 (8)0
  • a SV40(+), SV40 Tag sequence positive cases.

  • b SV40(−), SV40 Tag sequence negative cases.